AstraZeneca is buying Alexion Pharmaceuticals for $39 billion in stock and cash, its largest deal ever. The transaction values ...
Listen to the members of our team, working across AstraZeneca Vaccines and Immune therapies describe what their work means ...
Drugmakers AstraZeneca and Sanofi posted better-than-expected earnings for the first quarter. #News #Reuters #newsfeed ...
Data science and artificial intelligence (AI) have the potential to transform the way we discover and develop medicines. We know ...
AstraZeneca CEO Pascal Soriot joins 'Mad Money' host Jim Cramer to talk its lung cancer treatment, late stage drug development, ...
Explore the intersection of data-centric AI, machine learning, and the pharmaceutical industry with Ravi Gopalakrishnan, Global ...
From the beginning science has been at the front and centre of everything we do, taking us to places we never thought possible.
AstraZeneca Executive Vice-President of the Oncology Business Unit David Frederickson discusses the drugmaker's Enhertu ...
Discover how Data Visionary AstraZeneca is using cloud-ready data in their hybrid multicloud environment to advance, research, ...
AstraZeneca's Chief Executive Officer David Brennan tells us why a company's culture and spirit play an important role in bringing ...